It is easy to see why molecular biologist David Goeddel — the Genentech scientist who first created synthetic human insulin, human growth hormone and human tissue plasminogen activator — would ...
The treatment of choice would be a clot-busting medication called tissue plasminogen activator or tPA. It has risks, because the same chemicals that dissolve blood clots can cause serious internal ...
Add a description, image, and links to the office-2021 topic page so that developers can more easily learn about it.